Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-16 · accession 0001104659-24-109386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-17 | 2024-10-16 | APRE | Duey Marc | Dir | P - Purchase | $4.39 | +30.0K | 240.1K | +14% | +$131.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-16 | P | A | 30,000 | $4.39 | 240,113 | D | — | — |